Funder: Breakthrough T1D
Due Dates: January 10, 2025 (LOI) | February 21, 2025 (Full proposal, approved LOI required)
Funding Amounts: Up to $300,000 per year for 2 years (total max $600,000); higher budgets considered with prior approval.
Summary: Supports research to advance technologies that improve engraftment, survival, and function of insulin-producing cells at extrahepatic sites for type 1 diabetes cell therapy.